Product fact sheet
Fluconazole Tablets — Candidiasis Prescription Reference
Label-backed educational reference for prescription fluconazole tablets used in vaginal, oropharyngeal and esophageal candidiasis, with systemic safety and pregnancy boundaries.
Prescription systemic azole used across several candidiasis indications; regimen and safety considerations vary substantially by body site.
understanding systemic candidiasis treatment pathways, oral-thrush medicine comparisons
self-prescribing, treating every Candida-positive test, routine VVC treatment during pregnancy
Key tradeoff: Systemic reach versus broader interaction, hepatic, QT and pregnancy considerations.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
What it is
Fluconazole is a prescription systemic azole antifungal. Unlike nystatin suspension or clotrimazole troches, it is absorbed systemically and is used across several Candida indications.
One drug, very different regimens
The cited DailyMed label illustrates why the infection site matters:
- Vaginal candidiasis: a single oral dose is a labeled regimen in appropriate patients.
- Oropharyngeal candidiasis: multi-day treatment is used rather than the vaginal single-dose pattern.
- Esophageal candidiasis: treatment is longer and may use higher daily exposure depending on clinical response.
These regimens are not interchangeable.
Oral-thrush role
IDSA recommends oral fluconazole for moderate-to-severe oropharyngeal candidiasis. Mild disease may instead use local oral therapies such as clotrimazole troches or nystatin suspension.
See oral thrush treatments compared.
Pregnancy boundary
For vulvovaginal candidiasis during pregnancy, CDC recommends seven days of topical azole therapy and advises against oral fluconazole for routine treatment. This is an important example of why a prescription record cannot be reduced to “what works fastest.”
Systemic safety matters
Because fluconazole is systemic, clinicians consider interactions, liver disease, renal function, QT-prolongation risk and organism susceptibility where relevant. This reference is for comparison and understanding, not self-prescribing.
Primary references
- DailyMed, Fluconazole tablets: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4021916f-3063-4a89-a7a1-fe0705e36e22
- CDC STI Treatment Guidelines, Vulvovaginal Candidiasis: https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm
- IDSA Clinical Practice Guideline for the Management of Candidiasis: https://www.idsociety.org/practice-guideline/candidiasis/
Formula facts
Ingredients, actives and label details
- Candida indications
- Includes vaginal, oropharyngeal and esophageal candidiasis; regimen varies by site Basis: Government drug label Source: Fluconazole Tablets
- VVC pregnancy boundary
- CDC recommends 7-day topical azoles rather than oral fluconazole during pregnancy Basis: Clinical guideline Source: Vulvovaginal Candidiasis - STI Treatment Guidelines
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Safety first
What should make you slow down?
Fluconazole is a prescription systemic azole with clinically important interaction, liver, QT and pregnancy considerations. Dose and duration differ substantially by infection site; do not extrapolate the single-dose vaginal regimen to oral, esophageal or invasive candidiasis.
- Prescription medicine; treatment depends on body site, organism and patient factors.
- CDC recommends topical azoles rather than oral fluconazole for VVC during pregnancy.
- Review drug interactions and medical history with the prescriber or pharmacist.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- Fluconazole TabletsDailyMed, U.S. National Library of Medicine · Regulatory · retrieved 2026-08-11
- Vulvovaginal Candidiasis - STI Treatment GuidelinesCenters for Disease Control and Prevention · Clinical guideline · retrieved 2026-08-11
- Clinical Practice Guideline for the Management of Candidiasis: 2016 UpdateInfectious Diseases Society of America · Clinical guideline · retrieved 2026-08-11